Click for best price
Veterinary Vaccines Market Size, Share 2022
Vaccines play a crucial role in protecting animals from a large spectrum of diseases caused due to virus, bacteria, protozoa, and other multicellular pathogens.
This report contains market size and forecasts of Veterinary Vaccines in Global, including the following market information:
The global Veterinary Vaccines market was valued at 7184.8 million in 2021 and is projected to reach US$ 11310 million by 2028, at a CAGR of 6.7% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Inactivated Vaccines Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Veterinary Vaccines include Elanco, Merck, Merial, Zoetis, Advaxis, AmpliPhi Biosciences, Aratana Therapeutics, ARKO Labs and Bayer, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Veterinary Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Veterinary Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Type, 2021 (%)
- Inactivated Vaccines
- Live Attenuated Vaccines
- Conjugate Vaccines
- Toxoid Vaccines
- Recombinant Vaccines
- DNA Vaccines
- Others
Global Veterinary Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Veterinary Vaccines Market Segment Percentages, by Application, 2021 (%)
- Veterinary Clinic
- Veterinary Hospital
- Veterinary Research Institute
- Retail Pharmacy
- Others
Global Veterinary Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Veterinary Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Veterinary Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Veterinary Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Elanco
- Merck
- Merial
- Zoetis
- Advaxis
- AmpliPhi Biosciences
- Aratana Therapeutics
- ARKO Labs
- Bayer
- CanFel Therapeutics
- Ceva Animal Health
- Colorado Serum
- Epitopix
- Genus
- Hygieia Biological Laboratories
- ImmuCell
- Nexvet
- Nuovo Biologics
- UBI
- Valneva
- Vetoquinol
- Virbac
| Report Attributes |
Report Details |
| Report Title |
Veterinary Vaccines Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
118 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Veterinary Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Veterinary Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Veterinary Vaccines Overall Market Size
2.1 Global Veterinary Vaccines Market Size: 2021 VS 2028
2.2 Global Veterinary Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Veterinary Vaccines Players in Global Market
3.2 Top Global Veterinary Vaccines Companies Ranked by Revenue
3.3 Global Veterinary Vaccines Revenue by Companies
3.4 Top 3 and Top 5 Veterinary Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies Veterinary Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 Veterinary Vaccines Players in Global Market
3.6.1 List of Global Tier 1 Veterinary Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 Veterinary Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Veterinary Vaccines Market Size Markets, 2021 & 2028
4.1.2 Inactivated Vaccines
4.1.3 Live Attenuated Vaccines
4.1.4 Conjugate Vaccines
4.1.5 Toxoid Vaccines
4.1.6 Recombinant Vaccines
4.1.7 DNA Vaccines
4.1.8 Others
4.2 By Type - Global Veterinary Vaccines Revenue & Forecasts
4.2.1 By Type - Global Veterinary Vaccines Revenue, 2017-2022
4.2.2 By Type - Global Veterinary Vaccines Revenue, 2023-2028
4.2.3 By Type - Global Veterinary Vaccines Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Veterinary Vaccines Market Size, 2021 & 2028
5.1.2 Veterinary Clinic
5.1.3 Veterinary Hospital
5.1.4 Veterinary Research Institute
5.1.5 Retail Pharmacy
5.1.6 Others
5.2 By Application - Global Veterinary Vaccines Revenue & Forecasts
5.2.1 By Application - Global Veterinary Vaccines Revenue, 2017-2022
5.2.2 By Application - Global Veterinary Vaccines Revenue, 2023-2028
5.2.3 By Application - Global Veterinary Vaccines Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Veterinary Vaccines Market Size, 2021 & 2028
6.2 By Region - Global Veterinary Vaccines Revenue & Forecasts
6.2.1 By Region - Global Veterinary Vaccines Revenue, 2017-2022
6.2.2 By Region - Global Veterinary Vaccines Revenue, 2023-2028
6.2.3 By Region - Global Veterinary Vaccines Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Veterinary Vaccines Revenue, 2017-2028
6.3.2 US Veterinary Vaccines Market Size, 2017-2028
6.3.3 Canada Veterinary Vaccines Market Size, 2017-2028
6.3.4 Mexico Veterinary Vaccines Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Veterinary Vaccines Revenue, 2017-2028
6.4.2 Germany Veterinary Vaccines Market Size, 2017-2028
6.4.3 France Veterinary Vaccines Market Size, 2017-2028
6.4.4 U.K. Veterinary Vaccines Market Size, 2017-2028
6.4.5 Italy Veterinary Vaccines Market Size, 2017-2028
6.4.6 Russia Veterinary Vaccines Market Size, 2017-2028
6.4.7 Nordic Countries Veterinary Vaccines Market Size, 2017-2028
6.4.8 Benelux Veterinary Vaccines Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Veterinary Vaccines Revenue, 2017-2028
6.5.2 China Veterinary Vaccines Market Size, 2017-2028
6.5.3 Japan Veterinary Vaccines Market Size, 2017-2028
6.5.4 South Korea Veterinary Vaccines Market Size, 2017-2028
6.5.5 Southeast Asia Veterinary Vaccines Market Size, 2017-2028
6.5.6 India Veterinary Vaccines Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Veterinary Vaccines Revenue, 2017-2028
6.6.2 Brazil Veterinary Vaccines Market Size, 2017-2028
6.6.3 Argentina Veterinary Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Veterinary Vaccines Revenue, 2017-2028
6.7.2 Turkey Veterinary Vaccines Market Size, 2017-2028
6.7.3 Israel Veterinary Vaccines Market Size, 2017-2028
6.7.4 Saudi Arabia Veterinary Vaccines Market Size, 2017-2028
6.7.5 UAE Veterinary Vaccines Market Size, 2017-2028
7 Players Profiles
7.1 Elanco
7.1.1 Elanco Corporate Summary
7.1.2 Elanco Business Overview
7.1.3 Elanco Veterinary Vaccines Major Product Offerings
7.1.4 Elanco Veterinary Vaccines Revenue in Global Market (2017-2022)
7.1.5 Elanco Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Veterinary Vaccines Major Product Offerings
7.2.4 Merck Veterinary Vaccines Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Merial
7.3.1 Merial Corporate Summary
7.3.2 Merial Business Overview
7.3.3 Merial Veterinary Vaccines Major Product Offerings
7.3.4 Merial Veterinary Vaccines Revenue in Global Market (2017-2022)
7.3.5 Merial Key News
7.4 Zoetis
7.4.1 Zoetis Corporate Summary
7.4.2 Zoetis Business Overview
7.4.3 Zoetis Veterinary Vaccines Major Product Offerings
7.4.4 Zoetis Veterinary Vaccines Revenue in Global Market (2017-2022)
7.4.5 Zoetis Key News
7.5 Advaxis
7.5.1 Advaxis Corporate Summary
7.5.2 Advaxis Business Overview
7.5.3 Advaxis Veterinary Vaccines Major Product Offerings
7.5.4 Advaxis Veterinary Vaccines Revenue in Global Market (2017-2022)
7.5.5 Advaxis Key News
7.6 AmpliPhi Biosciences
7.6.1 AmpliPhi Biosciences Corporate Summary
7.6.2 AmpliPhi Biosciences Business Overview
7.6.3 AmpliPhi Biosciences Veterinary Vaccines Major Product Offerings
7.6.4 AmpliPhi Biosciences Veterinary Vaccines Revenue in Global Market (2017-2022)
7.6.5 AmpliPhi Biosciences Key News
7.7 Aratana Therapeutics
7.7.1 Aratana Therapeutics Corporate Summary
7.7.2 Aratana Therapeutics Business Overview
7.7.3 Aratana Therapeutics Veterinary Vaccines Major Product Offerings
7.7.4 Aratana Therapeutics Veterinary Vaccines Revenue in Global Market (2017-2022)
7.7.5 Aratana Therapeutics Key News
7.8 ARKO Labs
7.8.1 ARKO Labs Corporate Summary
7.8.2 ARKO Labs Business Overview
7.8.3 ARKO Labs Veterinary Vaccines Major Product Offerings
7.8.4 ARKO Labs Veterinary Vaccines Revenue in Global Market (2017-2022)
7.8.5 ARKO Labs Key News
7.9 Bayer
7.9.1 Bayer Corporate Summary
7.9.2 Bayer Business Overview
7.9.3 Bayer Veterinary Vaccines Major Product Offerings
7.9.4 Bayer Veterinary Vaccines Revenue in Global Market (2017-2022)
7.9.5 Bayer Key News
7.10 CanFel Therapeutics
7.10.1 CanFel Therapeutics Corporate Summary
7.10.2 CanFel Therapeutics Business Overview
7.10.3 CanFel Therapeutics Veterinary Vaccines Major Product Offerings
7.10.4 CanFel Therapeutics Veterinary Vaccines Revenue in Global Market (2017-2022)
7.10.5 CanFel Therapeutics Key News
7.11 Ceva Animal Health
7.11.1 Ceva Animal Health Corporate Summary
7.11.2 Ceva Animal Health Business Overview
7.11.3 Ceva Animal Health Veterinary Vaccines Major Product Offerings
7.11.4 Ceva Animal Health Veterinary Vaccines Revenue in Global Market (2017-2022)
7.11.5 Ceva Animal Health Key News
7.12 Colorado Serum
7.12.1 Colorado Serum Corporate Summary
7.12.2 Colorado Serum Business Overview
7.12.3 Colorado Serum Veterinary Vaccines Major Product Offerings
7.12.4 Colorado Serum Veterinary Vaccines Revenue in Global Market (2017-2022)
7.12.5 Colorado Serum Key News
7.13 Epitopix
7.13.1 Epitopix Corporate Summary
7.13.2 Epitopix Business Overview
7.13.3 Epitopix Veterinary Vaccines Major Product Offerings
7.13.4 Epitopix Veterinary Vaccines Revenue in Global Market (2017-2022)
7.13.5 Epitopix Key News
7.14 Genus
7.14.1 Genus Corporate Summary
7.14.2 Genus Business Overview
7.14.3 Genus Veterinary Vaccines Major Product Offerings
7.14.4 Genus Veterinary Vaccines Revenue in Global Market (2017-2022)
7.14.5 Genus Key News
7.15 Hygieia Biological Laboratories
7.15.1 Hygieia Biological Laboratories Corporate Summary
7.15.2 Hygieia Biological Laboratories Business Overview
7.15.3 Hygieia Biological Laboratories Veterinary Vaccines Major Product Offerings
7.15.4 Hygieia Biological Laboratories Veterinary Vaccines Revenue in Global Market (2017-2022)
7.15.5 Hygieia Biological Laboratories Key News
7.16 ImmuCell
7.16.1 ImmuCell Corporate Summary
7.16.2 ImmuCell Business Overview
7.16.3 ImmuCell Veterinary Vaccines Major Product Offerings
7.16.4 ImmuCell Veterinary Vaccines Revenue in Global Market (2017-2022)
7.16.5 ImmuCell Key News
7.17 Nexvet
7.17.1 Nexvet Corporate Summary
7.17.2 Nexvet Business Overview
7.17.3 Nexvet Veterinary Vaccines Major Product Offerings
7.17.4 Nexvet Veterinary Vaccines Revenue in Global Market (2017-2022)
7.17.5 Nexvet Key News
7.18 Nuovo Biologics
7.18.1 Nuovo Biologics Corporate Summary
7.18.2 Nuovo Biologics Business Overview
7.18.3 Nuovo Biologics Veterinary Vaccines Major Product Offerings
7.18.4 Nuovo Biologics Veterinary Vaccines Revenue in Global Market (2017-2022)
7.18.5 Nuovo Biologics Key News
7.19 UBI
7.19.1 UBI Corporate Summary
7.19.2 UBI Business Overview
7.19.3 UBI Veterinary Vaccines Major Product Offerings
7.19.4 UBI Veterinary Vaccines Revenue in Global Market (2017-2022)
7.19.5 UBI Key News
7.20 Valneva
7.20.1 Valneva Corporate Summary
7.20.2 Valneva Business Overview
7.20.3 Valneva Veterinary Vaccines Major Product Offerings
7.20.4 Valneva Veterinary Vaccines Revenue in Global Market (2017-2022)
7.20.5 Valneva Key News
7.21 Vetoquinol
7.21.1 Vetoquinol Corporate Summary
7.21.2 Vetoquinol Business Overview
7.21.3 Vetoquinol Veterinary Vaccines Major Product Offerings
7.21.4 Vetoquinol Veterinary Vaccines Revenue in Global Market (2017-2022)
7.21.5 Vetoquinol Key News
7.22 Virbac
7.22.1 Virbac Corporate Summary
7.22.2 Virbac Business Overview
7.22.3 Virbac Veterinary Vaccines Major Product Offerings
7.22.4 Virbac Veterinary Vaccines Revenue in Global Market (2017-2022)
7.22.5 Virbac Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Veterinary Vaccines Market Opportunities & Trends in Global Market
Table 2. Veterinary Vaccines Market Drivers in Global Market
Table 3. Veterinary Vaccines Market Restraints in Global Market
Table 4. Key Players of Veterinary Vaccines in Global Market
Table 5. Top Veterinary Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Veterinary Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Veterinary Vaccines Revenue Share by Companies, 2017-2022
Table 8. Global Companies Veterinary Vaccines Product Type
Table 9. List of Global Tier 1 Veterinary Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Veterinary Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global Veterinary Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Veterinary Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Veterinary Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global Veterinary Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Veterinary Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Veterinary Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global Veterinary Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Veterinary Vaccines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Veterinary Vaccines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Veterinary Vaccines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Veterinary Vaccines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Veterinary Vaccines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Veterinary Vaccines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Veterinary Vaccines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Veterinary Vaccines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Veterinary Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Veterinary Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Veterinary Vaccines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Veterinary Vaccines Revenue, (US$, Mn), 2023-2028
Table 30. Elanco Corporate Summary
Table 31. Elanco Veterinary Vaccines Product Offerings
Table 32. Elanco Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Veterinary Vaccines Product Offerings
Table 35. Merck Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 36. Merial Corporate Summary
Table 37. Merial Veterinary Vaccines Product Offerings
Table 38. Merial Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 39. Zoetis Corporate Summary
Table 40. Zoetis Veterinary Vaccines Product Offerings
Table 41. Zoetis Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 42. Advaxis Corporate Summary
Table 43. Advaxis Veterinary Vaccines Product Offerings
Table 44. Advaxis Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 45. AmpliPhi Biosciences Corporate Summary
Table 46. AmpliPhi Biosciences Veterinary Vaccines Product Offerings
Table 47. AmpliPhi Biosciences Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 48. Aratana Therapeutics Corporate Summary
Table 49. Aratana Therapeutics Veterinary Vaccines Product Offerings
Table 50. Aratana Therapeutics Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 51. ARKO Labs Corporate Summary
Table 52. ARKO Labs Veterinary Vaccines Product Offerings
Table 53. ARKO Labs Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 54. Bayer Corporate Summary
Table 55. Bayer Veterinary Vaccines Product Offerings
Table 56. Bayer Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 57. CanFel Therapeutics Corporate Summary
Table 58. CanFel Therapeutics Veterinary Vaccines Product Offerings
Table 59. CanFel Therapeutics Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 60. Ceva Animal Health Corporate Summary
Table 61. Ceva Animal Health Veterinary Vaccines Product Offerings
Table 62. Ceva Animal Health Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 63. Colorado Serum Corporate Summary
Table 64. Colorado Serum Veterinary Vaccines Product Offerings
Table 65. Colorado Serum Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 66. Epitopix Corporate Summary
Table 67. Epitopix Veterinary Vaccines Product Offerings
Table 68. Epitopix Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 69. Genus Corporate Summary
Table 70. Genus Veterinary Vaccines Product Offerings
Table 71. Genus Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 72. Hygieia Biological Laboratories Corporate Summary
Table 73. Hygieia Biological Laboratories Veterinary Vaccines Product Offerings
Table 74. Hygieia Biological Laboratories Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 75. ImmuCell Corporate Summary
Table 76. ImmuCell Veterinary Vaccines Product Offerings
Table 77. ImmuCell Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 78. Nexvet Corporate Summary
Table 79. Nexvet Veterinary Vaccines Product Offerings
Table 80. Nexvet Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 81. Nuovo Biologics Corporate Summary
Table 82. Nuovo Biologics Veterinary Vaccines Product Offerings
Table 83. Nuovo Biologics Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 84. UBI Corporate Summary
Table 85. UBI Veterinary Vaccines Product Offerings
Table 86. UBI Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 87. Valneva Corporate Summary
Table 88. Valneva Veterinary Vaccines Product Offerings
Table 89. Valneva Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 90. Vetoquinol Corporate Summary
Table 91. Vetoquinol Veterinary Vaccines Product Offerings
Table 92. Vetoquinol Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
Table 93. Virbac Corporate Summary
Table 94. Virbac Veterinary Vaccines Product Offerings
Table 95. Virbac Veterinary Vaccines Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Veterinary Vaccines Segment by Type in 2021
Figure 2. Veterinary Vaccines Segment by Application in 2021
Figure 3. Global Veterinary Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Veterinary Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Veterinary Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Veterinary Vaccines Revenue in 2021
Figure 8. By Type - Global Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 9. By Application - Global Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 10. By Region - Global Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 11. By Country - North America Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 12. US Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 16. Germany Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 17. France Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 24. China Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. India Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 30. Brazil Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Veterinary Vaccines Revenue Market Share, 2017-2028
Figure 33. Turkey Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Veterinary Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. Elanco Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Merial Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Zoetis Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Advaxis Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AmpliPhi Biosciences Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Aratana Therapeutics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. ARKO Labs Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bayer Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. CanFel Therapeutics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Ceva Animal Health Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Colorado Serum Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Epitopix Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Genus Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Hygieia Biological Laboratories Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. ImmuCell Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 53. Nexvet Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 54. Nuovo Biologics Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 55. UBI Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 56. Valneva Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 57. Vetoquinol Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 58. Virbac Veterinary Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
